Recall Register

Food, drugs, devices › Remel Inc

Device recall: Oxoid Antimicrobial Susceptibility Test Discs, Aztreonam 30 ug, IVD, REF CT0264B, Oxoid Ltd., UK, oxoid@thrmofisher.com

FDA enforcement event 63555 · Class II · initiated 21 Aug 2012 · status Terminated · terminated 4 Jun 2013

DeviceVoluntary: Firm initiated1 product recordLenexa, KS

FDA enforcement event 63555 is a device recall by Remel Inc of Lenexa, KS, initiated 21 Aug 2012 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 823 device enforcement events initiated in 2012 carry the same class.

Status: Terminated, terminated 4 Jun 2013. Initiation: voluntary: firm initiated. Remel Inc has 50 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Remel Inc, Lenexa, KS.

Reason for recall

"The firm is recalling the product due to some cartridges may contain individual discs that are not impregnated with antibiotic. The firm notified their customers of the recall with a notification letter and requested a confirmation fax back of receipt."

Distribution

"Nationwide Distribution including WI, MO, MA, CT, AL, IL, WA, CA, RI, MD, NJ, NC and TX."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0790-2013Oxoid Antimicrobial Susceptibility Test Discs, Aztreonam 30 ug, IVD, REF CT0264B, Oxoid Ltd., UK, oxoid@thrmofisher.com (Both Remel & Oxoid, Ltd are a part of Thermo Fisher Scientific) An antimicrobial susceptibility test disc is a device that consists of antimicrobic-impregnated paper discs used…30Class IITerminated13 Feb 2013

Context

88%of 2012 device events are Class II823 events that year
1product record in this eventfirm median: 1
50events on this register for the firm

Other enforcement events for Remel Inc

InitiatedProduct (first record)TypeClassRecords
3 Jun 2026GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460DeviceClass II1
24 Mar 2026Yeastone Broth, 11ML, 10/BOX YY3462DeviceClass II1
5 Feb 2026Campy CVA Medium 100/PK, R01272DeviceClass II1
12 Nov 20251. CAMHB W/LHB, MANUAL, 11ML, 10/BOX YCP112-10 2. BRUCELLA BROTH, 11ML, 10/BOX YT3450DeviceClass II1
11 Jul 2025Blood Agar,5% Sheep Blood 100/PK, Product Number R01202DeviceClass II4
1 May 2025Thermo SCIENTIFIC Sensititre Cation Adjusted AutoRead Mueller-Hinton Broth w/ TES w/ Lysed Horse Blood, REF CP11410; invDeviceClass II1
13 Feb 2025remel BLOOD AGAR MacCONKEY AGAR BIPLATE, REF R02049, QTY 100, for invitro diagnostic useDeviceClass II2
12 Feb 2025Zebra Thermal Barcode Printer GX430t, Model no. YSW 1000 or YSW 2000, may have been sold as an optional accessory for SeDeviceClass II1
20 Sep 2024remel BactiDrop Acridine Orange, REF 21502, 50 per package.DeviceClass II1
14 Aug 2023remel TODD HEWITT W. CNA (LIM BROTH), REF R064810; used to isolate Group B Streptococci form clinical specimens containiDeviceClass II1

All 50 events for Remel Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The firm is recalling the product due to some cartridges may contain individual discs that are not impregnated with antibiotic. The firm notified their customers of the recall with a notification letter and requested a confirmation fax back of receipt."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide Distribution including WI, MO, MA, CT, AL, IL, WA, CA, RI, MD, NJ, NC and TX."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 4 Jun 2013. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.